Oversonic Robotics: STMicroelectronics, Fondazione ENEA Tech Biomedical and SpotInvest acquire a stake in the Company

Oversonic Robotics, an Italian cognitive robotics company, has announced that it has secured a minority investment from STMicroelectronics, Fondazione ENEA Tech Biomedical, and SpotInvest. The transaction, which involves an undisclosed amount, aims to accelerate Oversonic's industrial, technological, and international development, particularly focusing on its flagship product, the cognitive humanoid robot RoBee. The announcement was made on June 23, 2026, and marks a significant step in the company's strategy to enhance its presence in the United States and expand its applications in various sectors.

The entry of these new shareholders is expected to bolster Oversonic's efforts in developing RoBee, which is the first certified cognitive humanoid robot designed for complex environments, including industrial and healthcare settings. STMicroelectronics, a leading global semiconductor company, will play a crucial role in advancing new technologies that are essential for the manufacturing sector. Fondazione ENEA Tech Biomedical is poised to support the development of certified humanoids specifically tailored for healthcare applications, while SpotInvest will facilitate the exploration of additional application areas related to services and process automation.

Oversonic's strategic focus on the United States as a key market reflects its ambition to position itself as a leader in the cognitive humanoids sector. The company has already established operational presence in the U.S. and aims to strengthen its relationships with industrial partners, investors, and clients. The investment from these notable shareholders is expected to create a robust ecosystem that fosters innovation and enhances the real-world applications of RoBee, ultimately driving the company's international growth.

The robotics and automation sector is experiencing significant momentum, driven by advancements in artificial intelligence and the increasing demand for efficiency and safety in manufacturing and healthcare. Oversonic's commitment to developing cognitive humanoid robots aligns with broader industry trends that emphasize the integration of robotics into everyday operations. As companies seek to enhance productivity and adapt to changing market conditions, investments in technologies like RoBee are likely to become increasingly valuable.

In conclusion, the minority investment in Oversonic Robotics by STMicroelectronics, Fondazione ENEA Tech Biomedical, and SpotInvest underscores the growing interest in cognitive robotics and its applications across various sectors. This transaction not only positions Oversonic for accelerated growth but also highlights the potential for humanoid robotics to transform industries by improving operational efficiency and enabling new capabilities. As the company embarks on this new phase of development, it is well-positioned to capitalize on the expanding market for cognitive humanoids, particularly in the United States and beyond.